I fully expect, and I will not try to stop a biosimilar IV version of KEYTRUDA coming on to the marketplace.
On the recordFebruary 8, 2024
Source
congress.govEditor's note · Context
Lujan expresses expectation for biosimilar market entry post-patent expiration.
Share
More from Ben Ray Luján
Jul 2, 2026
Today, the Supreme Court upheld a fundamental constitutional principle that has defined our nation for generations.
Jun 30, 2026
No senior should have to choose between getting the care they need and protecting their financial security.
Jun 27, 2026
Thousands of servicemembers, including many New Mexicans, bravely defended the Bataan Peninsula during World War II before enduring the Bataan Death March and imprisonment as prisoners of war," said Luján.
Jul 16, 2026
Congress set the national television ownership cap at 39 percent, and only Congress — not the FCC — has the authority to change it. It is clear that Chairman Carr is once again doing President Trump’s bidding.





